title: Type 1 interferons and myositis.
abstract: Recent studies suggest a mechanistic role for molecules induced by type 1 interferons in the pathogenesis of some forms of myositis. For dermatomyositis, evidence that these molecules injure myofibers seems especially strong. In the group of disorders known as polymyositis, the study of blood samples suggests a potential role. It is unknown what drives the sustained presence of type 1 interferon-inducible molecules in these diseases, as the type 1 interferons themselves have not been specifically detected along with their downstream biomarkers. Therapeutic development for blockade of IFNα is in progress aided by the identification of blood genomic biomarkers.
authors.affiliation: Department of Neurology, Division of Neuromuscular Disease, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. sagreenberg@partners.org
authors.forename: Steven A
authors.initials: SA
authors.lastname: Greenberg
mesh_terms: D015415:Biomarkers; D003882:Dermatomyositis / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000473:pathology; D003937:Diagnosis, Differential; D005786:Gene Expression Regulation / Q000276:immunology; D006801:Humans; D007370:Interferon Type I / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000097:blood / Q000235:genetics / Q000276:immunology*; D058990:Molecular Targeted Therapy; D018482:Muscle, Skeletal / Q000098:blood supply / Q000276:immunology / Q000473:pathology; D018979:Myositis, Inclusion Body / Q000097:blood / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000473:pathology; D009928:Organ Specificity; D017285:Polymyositis / Q000097:blood / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000097:blood; D053633:Receptor, Interferon alpha-beta / Q000037:antagonists & inhibitors / Q000502:physiology; D015398:Signal Transduction; D012867:Skin / Q000276:immunology / Q000473:pathology; D014158:Transcription, Genetic; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
chemical_list: D015415:Biomarkers; C507964:IFNAR1 protein, human; D007370:Interferon Type I; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D053633:Receptor, Interferon alpha-beta
references.citation: Brain. 2008 May;131(Pt 5):1228-40
references.pmid: 18420712
references.citation: Ann Rheum Dis. 2008 Dec;67(12):1670-7
references.pmid: 18272672
references.citation: Lancet. 1983 Jan 15;1(8316):127-8
references.pmid: 6129442
references.citation: FEBS Lett. 1998 Mar 20;425(1):112-6
references.pmid: 9541017
references.citation: N Engl J Med. 1979 Jul 5;301(1):5-8
references.pmid: 449915
references.citation: Ann Neurol. 2005 May;57(5):664-78
references.pmid: 15852401
references.citation: EMBO J. 1998 Nov 16;17(22):6660-9
references.pmid: 9822609
references.citation: Muscle Nerve. 2003 Dec;28(6):659-82
references.pmid: 14639580
references.citation: Science. 1982 Apr 23;216(4544):429-31
references.pmid: 6176024
references.citation: Arthritis Rheum. 2009 Jul;60(7):2193-200
references.pmid: 19565506
references.citation: Ann Neurol. 2010 Jan;67(1):53-63
references.pmid: 20186858
references.citation: Eur Neurol. 2008;59(3-4):159-63
references.pmid: 18230873
references.citation: Arthritis Rheum. 2007 Nov;56(11):3784-92
references.pmid: 17968926
references.citation: Lab Invest. 1985 Jun;52(6):638-49
references.pmid: 3892155
references.citation: Ann Rheum Dis. 1970 Jan;29(1):67-72
references.pmid: 5416101
references.citation: Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5
references.pmid: 12604793
references.citation: Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3372-7
references.pmid: 15728381
references.citation: Br J Dermatol. 2009 Feb;160(2):464-5
references.pmid: 19077075
references.citation: Arthritis Rheum. 2009 Jun;60(6):1815-24
references.pmid: 19479879
references.citation: J Neuroimmunol. 1995 Dec;63(1):9-16
references.pmid: 8557829
references.citation: Lab Invest. 1988 May;58(5):584-9
references.pmid: 2835552
references.citation: Clin Exp Immunol. 1986 Feb;63(2):450-8
references.pmid: 2421951
references.citation: Arthritis Rheum. 2007 Dec;56(12):3995-4004
references.pmid: 18050196
references.citation: J Neuropathol Exp Neurol. 1975 Jan;34(1):46-75
references.pmid: 1117321
references.citation: Hum Pathol. 1989 Mar;20(3):224-31
references.pmid: 2470663
references.citation: FEBS Lett. 1998 Dec 11;441(1):106-10
references.pmid: 9877175
references.citation: Mol Med. 2007 Jan-Feb;13(1-2):59-68
references.pmid: 17515957
references.citation: Ultrastruct Pathol. 1986;10(1):77-85
references.pmid: 3008393
references.citation: Arthritis Rheum. 1982 Apr;25(4):396-400
references.pmid: 6176247
references.citation: Neurology. 2007 Nov 20;69(21):2008-19
references.pmid: 17928577
references.citation: Autoimmunity. 2006 May;39(3):177-90
references.pmid: 16769651
references.citation: Immunity. 2000 Oct;13(4):539-48
references.pmid: 11070172
references.citation: Curr Opin Neurol. 2004 Jun;17(3):359-64
references.pmid: 15167072
references.citation: Cancer Res. 1984 Aug;44(8):3480-8
references.pmid: 6744275
references.citation: Arthritis Rheum. 1982 Apr;25(4):401-6
references.pmid: 6176248
references.citation: Arthritis Rheum. 2006 Jun;54(6):1906-16
references.pmid: 16736505
references.citation: Curr Opin Neurol. 2009 Oct;22(5):516-23
references.pmid: 19680126